References
- Paladino JA, Sperry HE, Backes JM, et al. Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics. Am J Med 1991; 91: 462–470.
- Bergan T, Thorsteinsson SB, Solberg R, Bjornskau L, Kolstad IM, Johnsen S. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses. Am J Med 1987; 82: 97–102.
- Shrire L, Saunders J, Traynor R, Koornhof HJ. A labo-ratory assessment of ciprofloxacin and comparable antimicro-bial agents. Eur J Clin Microbiol 1984; 3: 328–332.
- Cohn SM, Sawyer MD, Burns GA, Tolomeo C, Milner KA. Enteric absorption of ciprofloxacin during tube feeding in the critically ill. J Antimicrob Chemother 1996; 38: 871–876.
- De Marie S, VandenBergh MF, Buijk SL, et al. Bioavailability of ciprofloxacin after multiple enteral and intra-venous doses in ICU patients with severe gram-negative intra-abdominal infections. Intensive Care Med 1998; 24: 343–346.
- Shah A, Liu MC, Vaughan D, Heller AH. Oral bioequiv-alence of three ciprofloxacin formulations following single-dose administration: 500 mg tablet compared with 500 mg/10 mL or 500 mg/5 mL suspension and the effect of food on the absorption of ciprofloxacin oral suspension. J Antimicrob Chemother 1999; 43 (Suppl. A): 49-54.
- Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270: 2957–2963.
- Mehta AC. A critical appraisal of chromatographic and immunoassay techniques for clinical drug analysis. J Clin Pharm Ther 1992; 17: 325–331.
- Rowland M, Tucker G. Symbols in pharmacokinetics. J Pharmacokinet Biopharm 1980; 8: 497–507.
- Lettieri JT, Rogge MC, Kaiser L, Echols RM, Heller AH. Pharmacokinetic profiles of ciprofloxacin after single intravenous and oral doses. Antimicrob Agents Chemother 1992; 36: 993–996.
- MacGowan A, Rogers C, Bowker K. The use of in vitro pharmacodynamic models of infection to optimize fluo-roquinolone dosing regimens. J Antimicrob Chemother 2000; 46: 163–170.
- Ellner PD, Neu HC. The inhibitory quotient - A method for interpreting minimum inhibitory concentration data. JAMA 1981; 246: 1575–1578.
- MiMOZ O, Sinter V, Jacolot A, et al. Pharmacokinetics and absolute bioavailability of ciprofloxacin administered through a nasogastric tube with continuous enteral feeding to critically ill patients. Intensive Care Med 1998; 24: 1047–1051.
- Forrest A, Nix DE, Ballow CH, Goss TF, Birmingham MC, Schentag JJ. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob Agents Chemother 1993; 37: 1073–1081.
- Cohn SM, Cohn KA, Rafferty MJ, et al. Enteric absorption of ciprofloxacin during the immediate postopera-tive period. J Antimicrob Chemother 1995; 36: 717–721.